Stocks to buy

It may not be the “end all, be all” development for Bionano Genomics (NASDAQ:BNGO). But its strong fiscal performance last quarter isn’t something that should be ignored. Unfortunately, that’s what appears to be happening with BNGO stock post-earnings. Source: Natali_ Mis/ShutterStock.com Since releasing results after the close Nov. 4, the life sciences stock price has taken

As the first wave of the pandemic swept across countries in 2020, consumer spending fell dramatically. And companies rely on consumers to buy their goods and services. So, when consumer spending plateaued, consumer stocks also were in freefall. But the time is ripe for investors to get involved again. The consumer sector consists of companies

On Oct. 14, the Securities and Exchange Commission (SEC) released a report that tries to explain the saga that pushed up GameStop (NASDAQ:GME) over 10 times in price this year. For example, GME stock ended Dec. 31, 2020, at $18.84 and was trading for $208.64 by mid-day Nov. 18. Source: Northfoto / Shutterstock.com Moreover, at

SoFi Technologies (NASDAQ:SOFI) announced on Nov. 15 that a number of its original shareholders were going to sell some of their shares. This included Softbank (OTCMKTS:SFTBY), and some VC/private equity firms (Silver Lake Partners, Qatar Investment Authority, Red Crow Capital, LLC, etc.). The resulting sale of SOFI stock has pushed down the price by about

With ample liquidity in the financial system, 2021 has been a banner year for wealth creation. Be it equities or cryptocurrency, multifold returns over just a few months or even weeks have been frequent. Of course, there have been speculative stocks to buy among the top performers. However, I prefer to focus on non-speculative stories

Palantir (NYSE:PLTR) might be on cloud nine after posting another solid quarter of earnings. Altogether, when you add in several contract wins, it seems like the data analytics company can’t put a foot wrong. However, there are genuine concerns about overvaluation here. Right now, PLTR stock is trading at nearly 110 times forward earnings, according

Recently, shares of Palantir (NYSE:PLTR) sank over 10% following the release of its third-quarter results on Nov. 9. Coming off a low in mid-November last year, PLTR stock hit an all-time-high of $45 in late January. Now, the stock hovers around $22, down about 8% year-to-date (YTD). Source: Ascannio / Shutterstock.com A big data group,

Rocket Lab (NASDAQ:RKLB) is a small business in the space services business. But RKLB stock makes it seem like a big company. Source: Andrzej Puchta / Shutterstock.com Rocket Lab said it had $5.3 million in revenue during the third quarter. Its backlog stood at $183 million at the end of September, and the company expects

Lucid Group (NASDAQ:LCID) reported results for its first quarter as a publicly traded company this week. If Lucid was an established automaker like General Motors (NYSE:GM) or Toyota (NYSE:TM), we would be talking about the bottom line. For what it’s worth, the electric vehicle startup lost 43 cents per share for the third quarter, much

Palantir Technologies (NYSE:PLTR) reported third-quarter results on Nov. 9, meeting earnings expectations and delivering a revenue beat. The company continues to add new customers at a healthy pace with strong growth projected in the coming years. Though government revenue dipped during the quarter, the compelling strides in Palantir’s commercial segment have more than made up

Lucid Group (NASDAQ:LCID) just released its Q3 financial results on Nov. 15, showing that its order book is growing nicely. It is now clearly seen as a real force in the luxury end of the electric vehicle (EV) market. As a result, LCID stock is bound to move substantially higher from here. Source: Around the

Here’s an interesting addition to your biotechnology-sector holdings: California-headquartered Progenity (NASDAQ:PROG) develops targeted therapeutics for diseases, and traders should be glad to know that PROG stock is usually affordable. The stock’s low price makes it prone to bouts of volatility however, which are not helped by recent short-squeeze runs. But the big swings don’t mean there’s

There’s a pretty good chance that you haven’t spent much of your time thinking about functional materials. As an enterprising investor, however, you could discover serious profit potential with Meta Materials (NASDAQ:MMAT), as MMAT stock offers pure-play exposure to this high-conviction market. Source: Yuriy Golub / Shutterstock.com To put it simply, meta materials are a

If you’re looking to find stocks to buy on the dip, November provides slim pickings. That’s because the markets did well in October. The S&P 500 gained 6.9% last month, bringing its year-to-date return to 22.61%. In addition, the index had five new closing highs in October, bringing the YTD total to 59. Since 1950,

Novavax (NASDAQ:NVAX) bulls are finally rejoicing. Shares shot up after Indonesia, one of the top five most populous countries globally, greenlighted its vaccine recently. That came on the heels of the biotech filing emergency use authorization (EUA) packages with several authorities, including the world health organization (WHO) and the European Union (E.U.). All of this

GameStop (NYSE:GME) looks like it could be turning the corner financially. In its fiscal second-quarter results released on Sept. 8, sales rose to $1.183 billion from $942 million last year. Moreover, its net income loss was much lower than last year. Investors in GME stock could see a major turnaround sometime within the next year. Source:

Still stuck trading between $20 and $30 per share, it may seem like Palantir Technologies (NYSE:PLTR) is never bouncing back. But while returns with PLTR stock have been underwhelming over the past nine months, don’t get discouraged. Now is not the time to head for the exits. Source: Ascannio / Shutterstock.com Why? After its incredible run

Founded by somewhat eccentric billionaire Richard Branson, Virgin Galactic (NYSE:SPCE) is on a mission to make astronauts out of regular folks — who happen to have an extra several hundred thousand dollars lying around. You can invest in this intriguing mission with a position in SPCE stock. Source: Christopher Penler / Shutterstock.com To its credit, Branson’s

I have written several articles about AT&T (NYSE:T) and its proposed dividend cut. Suffice it to say that once the company spins off its Warner Media division and combines it with Discovery Inc (NASDAQ:DISCA), the dividend will be cut. That should occur sometime in 2022. For now, though, we can estimate where T stock will

Plant-based stocks have attracted significant investor interest in the past year. Data released by The Good Food Institute reveals that $3.1 billion in investment capital went into alternative proteins globally in 2020. That amount was three times the capital raised in 2019. In addition, Meticulous Research suggests the plant-based market will grow at a compounded